Lilly signs a $1B deal to deepen its oncology ties with China’s Innovent

Eli Lilly ($LLY) has expanded its R&D partnership with China's…

Novartis inks a string of deals to widen its immuno-oncology arsenal

Novartis ($NVS), developing cancer treatments that tap the power…

Moderna joins the personalized cancer vaccine rush with third new venture

Moderna Therapeutics is launching the third new personalized…

Cancer Vaccines Market Growing at 27% CAGR to 2019

The Global Cancer Vaccines Market 2015-2019 report says use of…